PDB, PDBj, PDBe, and RCSB PDB

  • The Protein Data Bank (PDB) is a global resource for storing, organizing, and distributing three-dimensional structural data of biological macromolecules, including proteins, nucleic acids, and their complexes. Structural information helps researchers understand molecular shape, biological function, molecular interactions, disease mechanisms, and the effects of genetic variation. The worldwide PDB (wwPDB) organization coordinates the management of the global archive through its partner organizations, including the Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB) in the United States, the Protein Data Bank in Europe (PDBe), and the Protein Data Bank Japan (PDBj). These organizations provide access to the same internationally coordinated collection of experimentally determined macromolecular structures, while offering different interfaces, analysis tools, and supporting services.
  • The PDB archive contains structures determined using experimental techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy (cryo-EM). Each structure is assigned a unique PDB identifier, which allows researchers to retrieve the corresponding structural record and connect it with related biological information. A PDB entry may include atomic coordinates, molecular sequences, experimental methods, resolution or other quality indicators, details of biological assemblies, ligand information, structural validation results, and references to scientific publications. The archive also includes structures of DNA, RNA, protein–nucleic acid complexes, viruses, ribosomes, enzymes, antibodies, membrane proteins, and other macromolecular systems.
  • RCSB PDB is the United States-based member of the wwPDB and provides a widely used portal for searching, viewing, downloading, and analyzing structural data. Its website supports searches by protein or gene name, organism, PDB identifier, molecular sequence, structural features, ligand, experimental method, and other criteria. Researchers can use its molecular visualization tools to inspect three-dimensional structures, examine binding sites, identify interacting residues, and explore molecular assemblies. RCSB PDB also connects structures to resources such as UniProt, PubMed, Gene Ontology, and chemical component databases, helping users relate structural observations to protein function, biological pathways, and published research.
  • PDBe, the Protein Data Bank in Europe, is operated by the European Bioinformatics Institute (EMBL-EBI). It provides access to PDB structures alongside tools for examining structural quality, biological assemblies, molecular interactions, sequence mappings, and related annotations. PDBe offers integration with other EMBL-EBI resources and supports programmatic access for computational research. Its services are useful when researchers need to connect macromolecular structures with protein sequences, functional annotations, molecular components, and other biological datasets. PDBe also provides tools that facilitate structural comparison and the exploration of relationships between structures and biological macromolecules.
  • PDBj, the Protein Data Bank Japan, is operated by the Protein Data Bank Japan organization at the Institute for Protein Research, Osaka University. It contributes to the international PDB archive and provides web-based tools for searching, viewing, and analyzing macromolecular structures. Its services include structural visualization, sequence-related searches, and access to associated biological information. PDBj also provides resources for structural data analysis and supports the use of PDB information in research and education. Together with RCSB PDB and PDBe, PDBj helps maintain global access to structural biology data for researchers in different regions and scientific communities.
  • Although RCSB PDB, PDBe, and PDBj provide access to the same coordinated archive, their websites and additional tools are not identical. Each portal may offer different search interfaces, visualizations, annotation displays, data-analysis functions, and methods of integration with other databases. A researcher may therefore begin with one portal and use another when a particular feature or analysis is more suitable. However, the three portals should not be treated as independent structural archives containing entirely separate collections. Their shared role is to provide access to and support the international PDB resource, with differences primarily in services, presentation, and supplementary analysis.
  • For bioinformatics workflows, PDB structures can be retrieved manually through web interfaces or programmatically through supported APIs and bulk-download services. Structural records are commonly distributed in the macromolecular Crystallographic Information File format, known as mmCIF, which is well suited to modern structural data and can represent information that exceeds the limitations of older PDB-format files. Legacy PDB-format files remain available for many entries, but mmCIF is generally preferred for new computational workflows. Researchers should record the PDB identifier, file format, retrieval date, relevant structure version or revision information, and any processing steps applied to the downloaded data. This practice improves reproducibility and helps distinguish between the original deposited structure and a subsequently updated record.
  • These resources are widely used in protein structure analysis, molecular docking, drug discovery, structural comparison, evolutionary studies, protein engineering, and the investigation of disease-associated variants. For example, a researcher studying an enzyme may retrieve its structure from RCSB PDB, inspect active-site residues, compare the structure with related proteins through PDBe tools, and use PDBj resources to explore additional structural information. A drug-discovery project may examine a protein–ligand complex to identify interactions between the target protein and a bound compound. Similarly, researchers studying a disease-associated mutation can use a structure to investigate whether the altered residue lies near an active site, an interaction interface, or a region important for protein stability.
  • PDB resources also have limitations that researchers must consider. Not every biological molecule has an experimentally determined structure, and some deposited structures represent only part of a protein or a particular molecular state. Structural quality varies with experimental method, resolution, model completeness, and the quality of the deposited data. Flexible regions may be unresolved, and a structure obtained under laboratory conditions may not fully represent the molecule’s behavior in a living organism. In addition, the biological assembly proposed for a structure may differ from the arrangement observed in the crystal or experimental sample. Predicted structures, such as those available through AlphaFold Database, can complement experimental resources, but they should be distinguished from experimentally determined PDB entries.
  • When interpreting a structure, researchers should examine experimental details, validation reports, missing residues, ligand assignments, biological assembly information, and the evidence supporting the proposed molecular interpretation. Structural coordinates alone do not prove a particular biological function or interaction. Strong conclusions often require integration with biochemical experiments, genetic evidence, sequence analysis, functional annotations, and other relevant data. Researchers should also avoid assuming that the highest-resolution structure is automatically the most biologically appropriate model; the best choice depends on the research question, molecular state, ligand, and experimental context.
  • In summary, PDB, PDBj, PDBe, and RCSB PDB are central resources in structural bioinformatics. The wwPDB partners coordinate the international archive, while their individual portals provide complementary tools for retrieving, visualizing, validating, and analyzing macromolecular structures. Understanding their shared role, their distinct services, and the limitations of structural data enables researchers to use three-dimensional molecular information more accurately in bioinformatics, structural biology, biotechnology, and drug discovery.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *